Eva Shrestha Email & Phone Number

Cambridge, Cambridgeshire, GB

Boston, MA, US

• Led medical communications strategy and execution for Cystic Fibrosis disease state and 4 approved and pipeline CF products. Awarded 10+ peer recognition for demonstrating values of collaboration, excellence, and.
• Medical content development: Planned, developed and trained over 30 materials for external and internal scientific communication including slide decks and interactive posters.
• Internal resource and process development: Created and maintained 5+ internal resources for cross-functional partners that facilitated day-to-day work, e.g., publication repository and curated weekly literature alert.
• Medical education and training: Designed and executed medical training plan including interactive training module supporting education on new product data for onboarding and launch readiness. Training designed with.
• Congress Content Planning and Support: Planned and executed interactive Medical education booth materials for 4+ high priority international congresses. Acted as the Sci Comms congress lead for an international high.
• Global Launch GSC lead: Co-led scientific communication plans for two Global launches as part of the cross-functional launch readiness team.

Cambridge, MA, US

• Led medical communications strategy and execution of timely and accurate scientific material on Alzheimer’s disease (AD) franchise and ADUHELM (aducanumab).
• Developed Global Medical materials including briefing documents for high priority publications; regulatory, and safety updates; field slide decks for disease state and production specific education; and publications.
• Trained medical and commercial colleagues on medical materials
• Contributed to crafting of strategic scientific messaging and materials based on scientific evidence on aducanumab.
• Led company-wide weekly literature updates including rapid turnaround strategic summaries for key scientific publications on AD
• Collaborated cross-functional with colleagues in Medical Information, Medical Directors’ office, MSLs, Commercial, Value and Access, and regional affiliates, including the US and Europe, to execute medical deliverables.

Cambridge, MA, US

• Gained broad exposure to medical affairs through rotations in scientific communication, Global and US Medical director’s offices, and commercial functions.
• Led key opinion leader engagement through 2 Global advisory boards to share a product narrative for a MS product
• Supported Global Medical training for launch preparedness of VUMERITY (Diroximal fumarate) in 19+ affiliate regions.
• Developed long-term strategic narratives, medical planning, data generation timelines, market research and planning for marketed and pipeline products
• Contributed to congress-related activities including data generation, planning and execution, coverage, competitive intelligence, and review.
• Developed medical communication materials including medical briefing documents, FAQs, publication extenders such as infographics, and regulatory briefs

Baltimore, MD, US

• Graduate Thesis Advisor: Dr. Karen S. SfanosLed multiple projects establishing the role of microbiome and infections in prostate carcinogenesis.
• Designed, conducted, and analyzed experiments on patient derived tissues and cell culture models leading a multidisciplinary team
• Published 5 scientific manuscripts with 2 first author publications in peer reviewed journals and presented in over 15 institutional and national conferences
• Mentored 3 medical and graduate trainees to design and conduct research that resulted in a publication and over 5 national and institutional presentations

Senior Thesis under Dr. Michael TibbettsStudied the role of cell-cell adhesion molecule on the distribution and formation of hair cells in Danio rerio (Zebra fish) model1) Designed and conducted experiments to show the distribution of protocadherins in zebrafish larvae during development at mRNA (RT- PCR) and protein levels (IHC)3) Used knockdown models.

Research with Dr. Michael TibbettsWorked on the study of efficiency of potential anti-cancer drug (AH-197) as compared to commercially available drugs on human cancer cell lines.Worked on the comparison between the effects of Cisplatin and AH-197(a novel compound) on wild type and mutant yeast strains.Research with Dr. Philip JonesStudied genetic traits of.

Office management and office assistant under the guidance of Anne Canzonetti and Jane Brien, 1) Managed alumni records for the Bard College Alumni network for multiple projects. 2) Helped organize multiple events serving the Bard College alumni network and connecting students to alumni network.

New York, NY, US

Under the guidance of Dr. Leslie Vosshall and Dr. Benjamin Matthews, studied the effects of humidity and molarity of solution on the ovi-position behavior of female Aedes aegypti.1) Studied the role of humidity of environment and molarity of egg laying solution on the oviposition behavior of female Aedes aegypti.2) Designed apparatus setup and executed.

Baton Rouge, LA, US

Under the guidance of Dr. Kenneth Eilertson- studied the efficiency of de-differentiation and directional differentiation of various human induced pluripotent stem cells.

Boston, MA, US

Under the guidance of Dr. Mireya Nadal-Vicens, Dr. Jordan Smoller and Dr. Edward Kravitz -1) Studied the potential of Drosophila melanogaster as a model for testing anti depression drugs2) Analyzed videos for Drosophila aggression and behavior patterns to demonstrate Drosophila as a viable model for preliminary drug testing for depression

Kathmandu, NP

Intern helping with day to day lab work and learning important lab skills

Doctor Of Philosophy (Ph.D.), Pathobiology

Bachelor Of Arts (B.A.), Biology